Adenine Deoxy Nucleoside

Also known as: Adenine Deoxyribonucleoside Adenine Deoxyribose Adenine Nucleoside Adenine Riboside Adenosine Adenyldeoxyriboside Deoxyadenosine Desoxyadenosine

Active ingredient description

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Adenosine
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB10

Medicines

Adenine Deoxy Nucleoside is the active ingredient of these drugs:

Drug
Countries

Brazil Canada United States

Estonia Ireland Lithuania Netherlands New Zealand

France Hong Kong Spain United Kingdom

Estonia Lithuania

France Tunisia

Spain

Ecuador

France

Brazil

France

Ecuador

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 267.241 g/mol

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 58-61-7
DrugBank Drug: DB00640
KEGG Drug: D00045
RxNorm Ingredient: 296
SNOMED-CT Concept: 35431001
Adenosine (substance)
UNII Identifier: K72T3FS567
ADENOSINE